María Eugenia-Toledo-Romaní, Leslyhana Verdecia-Sánchez, Meiby Rodríguez-González, Laura Rodríguez-Noda, Carmen Valenzuela‐Silva, Beatriz Paredes-Moreno, Belinda Sánchez-Ramírez, Rocmira Pérez-Nicado, Raúl González-Mugica, Tays Hernández-García, Gretchen Bergado, Franciscary Pi-Estopiñán, Otto Cruz-Sui, Anitza Fraga-Quintero, Majela García-Montero, Ariel Palenzuela-Díaz, Gerardo Baró-Román, Ivis Mendoza-Hernández, Sonsire Fernández-Castillo, Yanet Climent-Ruíz, Darielys Santana-Mederos, Ubel Ramírez Gonzalez, Yanelda García-Vega, Beatriz Pérez-Massón, Guang-Wu-Chen, Tammy Boggiano-Ayo, Eduardo Ojito-Magaz, Daniel G. Rivera, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Vérez-Bencomo, Yanet Gómez-Maceo, Radamet Reyes-Matienzo, José Manuel Coviella-Artime, Irania Morffi-Cinta, Marisel Martínez-Pérez, Ismavy C. Castillo-Quintana, Aniurka Garcés-Hechavarría, Rodrigo Valera-Fernández, Dayle Martínez-Bedoya, Raine Garrido-Arteaga, Félix Cardoso-SanJorge, Lauren Quintero Moreno, Ivis Ontivero-Pino, María Teresa Pérez-Guevara, Marilin Morales-García, Enrique Noa-Romero, Ivette Orosa-Vázquez, Marianniz Díaz-Hernández, Gertrudis Rojas, Yaima Tundidor, Elena García-López, Yaima Muñoz-Morejon, Evelyn Galano-Frutos, Julián Rodríguez-Alvarez, Amaylid Arteaga, Maite Medina Nápoles, Jennifer Espi Ávila, Marcos Fontanies Fernández,
SOBERANA 02 is a COVID-19 vaccine based on SARS-CoV-2 recombinant RBD conjugated to tetanus toxoid ( ... and IIa clinical trials using two-doses of SOBERANA 02 and three-doses (homologous) or heterologous (with SOBERANA ... to evaluate safety and explore the immunogenicity of SOBERANA 02 in two formulations (15 or 25 μg RBD- ... volunteers 19-80-years, receiving two doses of SOBERANA 02-25 μg. In both trials, half of volunteers ... to receive a third dose of the corresponding SOBERANA 02 and half received a heterologous dose of SOBERANA ...
Tópico(s): Viral Infections and Immunology Research
2022 - Elsevier BV | Vaccine
María Eugenia Toledo-Romaní, Mayra García-Carmenate, Leslyhana Verdecia-Sánchez, Suzel Pérez-Rodríguez, Meybis Rodriguez-González, Carmen Valenzuela‐Silva, Beatriz Paredes-Moreno, Belinda Sánchez-Ramírez, Raúl González-Mugica, Tays Hernández-García, Ivette Orosa-Vázquez, Marianniz Díaz-Hernández, María Teresa Pérez-Guevara, Juliet Enríquez-Puertas, Enrique Noa-Romero, Ariel Palenzuela-Díaz, Gerardo Baró-Román, Ivis Mendoza-Hernández, Yaima Muñoz, Yanet Gómez-Maceo, Bertha Leysi Santos-Vega, Sonsire Fernández-Castillo, Yanet Climent-Ruíz, Laura Rodríguez-Noda, Darielys Santana-Mederos, Yanelda García-Vega, Guang‐Wu Chen, Delaram Doroud, Alireza Biglari, Tammy Boggiano-Ayo, Yury Valdés-Balbín, Daniel G. Rivera, Dagmar García-Rivera, Vicente Vérez-Bencomo, Mailin Cubas-Curbelo, Pedro Gabriel Rodríguez-Castillo, Yosmel Acevedo-Martínez, Solangel Estoque-Cabrera, José Alejandro Ávila-Cabreja, Ainadis Alfaro-Guzmán, Lilian Zulueta-Pérez, Niurka Tamara Espino-Rojas, Gloria Margarita Medinas-Santos, Ileana Luisa Sarda-Rodriguez, Mario Alejandro Acosta-Martinez, Radamet Reyes-Matienzo, José Manuel Coviella-Artime, Irania Morffi-Cinta, Marisel Martínez-Pérez, Rodrigo Valera-Fernández, Aniurka Garcés-Hechavarría, Dayle Martínez-Bedoya, Raine Garrido-Arteaga, Félix Cardoso-SanJorge, Ubel Ramírez-Gonzalez, Lauren Quintero-Moreno, Ivis Ontivero-Pino, Roselyn Martínez-Rivera, Berta Guillén-Obregón, Janet Lora-García, Maite Medina-Nápoles, Jennifer Espi-Ávila, Marcos Fontanies-Fernández, Yeney Regla Domínguez-Pentón, Gretchen Bergado, Franciscary Pi-Estopiñán, Eduardo Ojito-Magaz, Misladys Rodríguez, Otto Cruz-Sui, Majela García-Montero, Marta Dubed-Echevarría, Elena García-López, Evelyn Galano-Frutos, Alina Perez-Perez, Susana Morales-Ruano, Idalmis Brito-Pascual, Maité Amoroto, Amaylid Arteaga-García,
Summary Background SOBERANA 02 has been evaluated in phase I and IIa studies comparing homologous versus heterologous schedule (this one, including SOBERANA ... report results of immunogenicity, safety, and reactogenicity of SOBERANA 02 in a two- or three-dose heterologous scheme ... SARS-CoV-2 RBD conjugated to tetanus toxoid (SOBERANA 02) and a third dose of dimeric RBD (SOBERANA ... apart; two production batches of active ingredients of SOBERANA 02 were evaluated. Primary outcome was the percentage of ... the most frequent AE. Conclusions Two doses of SOBERANA 02 were safe and immunogenic in adults. The heterologous ...
Tópico(s): Long-Term Effects of COVID-19
2022 - Elsevier BV | Med
ABSTRACT Background SOBERANA 02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoid). Phase 1 and 2 clinical trials ... to three groups to receive a) two doses, SOBERANA 02, or b) two doses, SOBERANA 02 and a third dose, SOBERANA Plus, or c) ... gradually to 100% δ. Results Two doses of SOBERANA 02 protected against symptomatic COVID-19: 43 cases in ... dose, heterologous COVID-19 vaccine. Two doses of SOBERANA 02 were safe and attained efficacy of 71.0% in the adult population 19-80 y/o; incorporating SOBERANA Plus increased efficacy from 71.0 % to 92. ...
Tópico(s): interferon and immune responses
2003 - BMJ | Journal of Medical Genetics
María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela‐Silva, Waldemar Baldoquín Rodríguez, Marisel Martínez-Pérez, Meiby Rodríguez-González, Beatriz Paredes-Moreno, Ivis Mendoza-Hernández, Raúl González-Mujica Romero, Oscar Samón-Tabío, Pablo Velazco-Villares, Juan Pablo Bacallao-Castillo, Ernesto Licea-Martín, Misladys Rodríguez-Ortega, Nuris Herrera-Marrero, Esperanza Caballero-González, Liudmila Egües-Torres, Reinaldo Duartes-González, Serguey García-Blanco, Suzette Pérez-Cabrera, Santos Huete-Ferreira, Kirenia Idalmis-Cisnero, Omayda Fonte-Galindo, Dania Meliá-Pérez, Ivonne Rojas-Remedios, Delaram Doroud, Mohammad Mehdí Gouya, Alireza Biglari, Sonsire Fernández-Castillo, Yanet Climent-Ruíz, Yury Valdés-Balbín, Dagmar García-Rivera, Patrick Van der Stuyft, Vicente Vérez-Bencomo,
SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoid). Phases 1/2 clinical ... efficacy of two immunisation regimes: two doses of SOBERANA-02 and a heterologous three-dose combination with SOBERANA- ... controlled, phase-3 trial evaluating a two doses SOBERANA-02 scheme and a heterologous scheme with one dose ... 6 in the placebo group. Two doses of SOBERANA-02 was 69.7% (95%CI 56.5-78. ...
Tópico(s): vaccines and immunoinformatics approaches
2022 - Elsevier BV | The Lancet Regional Health - Americas
... clinical trials of the Finlay Vaccine Institute's Soberana 02 and Soberana Plus vaccines in pediatric ages. Dr Puga's ...
Tópico(s): Immunodeficiency and Autoimmune Disorders
2022 - | MEDICC Review
María Eugenia-Toledo-Romaní, Mayra García Carmenate, Carmen Valenzuela‐Silva, Waldemar Baldoquín Rodríguez, Marisel Martínez-Pérez, Meiby Rodríguez-González, Beatriz Paredes-Moreno, Ivis Mendoza-Hernández, Raúl González-Mugica, Oscar Samón-Tabío, Pablo Velazco-Villares, Juan Pablo Bacallao-Castillo, Ernesto Licea-Martín, Misladys Rodríguez-Ortega, Nuris Herrera-Marrero, Esperanza Caballero-González, Liudmila Egües-Torres, Reinaldo Duartes-González, Serguey García-Blanco, Suzette Pérez-Cabrera, Santos Huete-Ferreira, Kirenia Idalmis-Cisnero Idalmis-Cisnero, Omayda Fonte-Galindo, Dania Meliá-Pérez, Ivonne Rojas-Remedios, Delaram Doroud, Mohammad Mehdí Gouya, Alireza Biglari, Patrick Van der Stuyft Van der Stuyft, Sonsire Fernández-Castillo, Yanet Climent-Ruíz, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Vérez-Bencomo,
Background: SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoid). Phases 1/2 clinical trials ... controlled, phase-3 trial evaluating two doses of SOBERANA-02 and a heterologous scheme with one dose SOBERANA- ... 100% against severe COVID-19. Two doses of SOBERANA-02 was 69·7% (95%CI 56·5-78· ...
Tópico(s): COVID-19 Clinical Research Studies
2022 - RELX Group (Netherlands) | SSRN Electronic Journal
... Cuba has three vaccines authorized for emergency use-Soberana 02 and Soberana Plus developed by IFV, and Abdala, developed by ...
Tópico(s): Healthcare Systems and Reforms
2022 - | MEDICC Review
Rocmira Pérez-Nicado, Chiara Massa, Laura Rodríguez-Noda, Anja Müller, Rinaldo Puga-Gómez, Yariset Ricardo-Delgado, Beatriz Paredes-Moreno, Meiby Rodríguez-González, Marylé García-Ferrer, Ilianet Palmero-Álvarez, Aniurka Garcés-Hechavarría, Daniel G. Rivera, Yury Valdés-Balbín, Vicente Vérez-Bencomo, Dagmar García-Rivera, Barbara Seliger,
... 11 years) vaccinated with the RBD-based vaccines SOBERANA® 02 and SOBERANA® Plus combined in a heterologous scheme ... 4) Conclusions: Vaccination with the heterologous scheme of SOBERANA® 02/SOBERANA® Plus induces a stronger antibody and cellular immune ...
Tópico(s): Viral gastroenteritis research and epidemiology
2023 - Multidisciplinary Digital Publishing Institute | Vaccines
Ehsan Mostafavi, Sana Eybpoosh, Mohammad Karamouzian, Malahat Khalili, Saiedeh Haji‐Maghsoudi, Mostafa Salehi‐Vaziri, Ali Khamesipour, Tahmineh Jalali, Mehran Nakhaeizadeh, Hamid Sharifi, Yasaman Mansoori, Fariba Keramat, Samad Ghodrati, Mostafa Javanian, Delaram Doroud, Mir Davood Omrani, Hassan Asadi, Mohammad Hassan Pouriayevali, Roya Ghasemian, Hossein Farshidi, Morteza Pourahmad, Iman Ghasemzadeh, Leila Mounesan, Maryam Darvishian, Mohamad Reza Mirjalili, María Eugenia Toledo-Romaní, Carmen Valenzuela‐Silva, Vicente Vérez-Bencomo, Mohammad Mehdí Gouya, Hamid Emadi-Koochak, Ali Akbar Haghdoost, Alireza Biglari, Behnaz Soleimani Tappeh Sari, Soheil Ebrahimpour, Rostam Heydar Tabar, Roghayye Vaseghi, Bahram Mirzaei, Mehdi Safarpour, Farzin Sadeghi, Mahmoud Hosseinpoor, Tayebeh Raznahan, Leila Haddadi, Arezoo Mobarak Abadi, Elham Khalili, Mehrsa Manaei, Hassan Morshedi, Hamed Gooklani, Manoochehr Karami, Mohammad Khazaei, Seyyed Jalaleddin Bathaei, Ali Ataei, Ali Zahiri, Zahra Eskandari, Firouzeh Karbalaei Zadeh, Elham Abdoli, Marzieh Arjmandian, Maryam Zamanian, Razieh Sadat Mirmoeini, Seyyede Zeinab Hashemi, Farid Azizi Jalilian, Kamal Heidari, Mehdi Farsi, Mahnaz Mostajeran, Marjan Mashkooti, Somayye Davashi, Nastaran Kian Poor, Asefeh Haddadpour, Fariba Mazrooei, Hossein Safizadeh, Mohammad Reza Naghavi, Saeed Sohbati, Nadia Mohit Kermani, Nasim Nasiri Moghaddam, Shahriar Dabiri, Ghasem Oveis, Mohammadreza Parsaei, Maghsood Khalizadeh, Abbas Arjmand, Fatemeh Yazdi Zadeh, Hadi Dehbashi araghdari, Zainab Bandalizadeh, Mohammadreza Dehghani, Mehrdad Mansouri, Masoud Sharifi, Hossein Shojaei Far, Javad Soheili, Sina Owlia, Masoumeh Mazidi, Mohammad Sharif Yazdi, Mahdieh Bahri, Razieh Sadat Hashemi, Alireza Talebi, Saeideh Anvari, Ahmad Jonidi Jafari, Mohammadreza Saeini, Fariba Najafi, Davoud Rahmani, Ali Seidy, Mahshid Hajikhani, Hossein Dinmohammadi, Amir Javadi, Seyed Ebrahim Eskandari, Farhad Handjani, Maryam Chegeni, Katayoun Seif Farahi, Payman Hemmati, Mahsa Tavakoli Rad, Zahra Fereidooni, Sahar Khakifirouz, Tahereh Mohammadi, Mehdi Fazlalipour, Ali Maleki, Amir Hesam Nemati, Ahmad Ghasemi, Sanam Azad Manjiri, Zahra Ahmadi, Parastoo Yekta Sanati, Setareh Kashanian, Mohammad Mehdi Mortazavipoor, Laya Farhan Asadi, Zahra Hosseini, Farideh Niknam Oskouei, Sepideh Gerdooie, Marzyie Sajadi, Maryam Rostamtabar, Talieh Sabouni, Alireza Rahimi, Alireza Kavianpour, Seyed Mohsen Zahraei, Katayoun Tayeri, Ali Amin, Hamid Reza Tohidinik, Azam Rastegari, Soheil Mehmandoost,
... based SARS-CoV-2 vaccines FINLAY-FR-2 (Soberana 02) and FINLAY-FR-1A (Soberana Plus) showed good safety and immunogenicity in phase ...
Tópico(s): Viral gastroenteritis research and epidemiology
2023 - American Medical Association | JAMA Network Open
Rinaldo Puga-Gómez, Yariset Ricardo-Delgado, Chaumey Rojas-Iriarte, Leyanis Céspedes-Henriquez, Misleidys Piedra-Bello, Dania Vega-Mendoza, Noelvia Pestana Pérez, Beatriz Paredes-Moreno, Meiby Rodríguez-González, Carmen Valenzuela‐Silva, Belinda Sánchez-Ramírez, Laura Rodríguez-Noda, Rocmira Pérez-Nicado, Raúl González-Mugica, Tays Hernández-García, Talía Fundora-Barrios, Martha Dubet Echevarría, Juliet Enríquez-Puertas, Yenicet Infante-Hernández, Ariel Palenzuela-Díaz, Evelyn Gato-Orozco, Yanet Chappi-Estévez, Julio Cesar Francisco-Pérez, Miladi Suarez-Martinez, Ismavy C. Castillo-Quintana, Sonsire Fernández-Castillo, Yanet Climent-Ruíz, Darielys Santana-Mederos, Yanelda García-Vega, María Eugenia Toledo-Romaní, Delaram Doroud, Alireza Biglari, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Vérez-Bencomo, María Elena Mesa-Herrera, Yarmila García-Cristiá, Leonor Verdecia-Sánchez, Rafael del Valle Rodríguez, Yudalvies Oquendo-de la Cruz, Daysi Álvarez-Montalvo, Randy Grillo-Fortún, Liset López-González, Omaida Fonte Galindo, Yeseni Reyes-González, Ana Beatriz González-Álvarez, Linet Gorrita-Mora, Rodrigo Valera-Fernández, Ivis Ontivero-Pino, Marisel Martínez-Pérez, Esperanza Caballero-González, Aniurka Garcés-Hechavarría, Dayle Martínez-Bedoya, Maite Medina-Nápoles, Yeney Regla Domínguez-Pentón, Yadira Cazañas-Quintana, Thais Fundora Barrios, Diana Rosa Hernández Fernández, Gretchen Bergado, Ivette Orosa-Vázquez, Franciscary Pi-Estopiñán, Marianniz Díaz-Hernández, Otto Cruz-Sui, Enrique Noa-Romero, Arilia García-López, Sandra Rivadereira Muro, Gerardo Baró-Román,
... two doses of FINLAY-FR-2 (subsequently called SOBERANA 02) and the third heterologous dose of FINLAY-FR-1A (subsequently called SOBERANA Plus) in 350 children 3-18 y/o ...
Tópico(s): Vaccine Coverage and Hesitancy
2022 - Elsevier BV | International Journal of Infectious Diseases
María Eugenia Toledo-Romaní, Carmen Valenzuela‐Silva, Minerva Montero-Díaz, Luisa Iñiguez-Rojas, Meiby Rodríguez-González, Mery Martínez-Cabrera, Rinaldo Puga-Gómez, Angel German-Almeida, Sonsire Fernández-Castillo, Yanet Climent-Ruíz, Darielys Santana-Mederos, Lissette López-González, Ileana Morales-Suárez, Delaram Doroud, Yury Valdés-Balbín, Dagmar García-Rivera, Patrick Van der Stuyft, Vicente Vérez-Bencomo,
... of existing vaccines. The protection provided by the SOBERANA-02-Plus vaccination scheme against this variant has not ...
Tópico(s): COVID-19 Clinical Research Studies
2024 - Elsevier BV | The Lancet Regional Health - Americas
... the time of writing, a second vaccine candidate, SOBERANA 02, was in late-stage development and preparing to ...
Tópico(s): Healthcare Systems and Reforms
2020 - | MEDICC Review
Tania L. Aguilar-Guerra, Esther María Fajardo Díaz, Conner Gorry,
... had received at least their first dose of Soberana 02 or Abdala, two of five vaccine candidates for ...
Tópico(s): SARS-CoV-2 and COVID-19 Research
2021 - | MEDICC Review
José Víctor Zambrana, Carlos Saenz, Hannah E. Maier, M Brenes, Andrea C. Nunez, Anita Matamoros, Mabel Hernández, Keyla Dumas, Cristhian Toledo, Leonardo Peralta, Aubree Gordon, Ángel Balmaseda,
... ChAdOx1-S), alongside less-studied vaccines including Soberana (Soberana 02), Abdala (CIGB-66), and Sputnik V/Sputnik Light. Overall, 3195 individuals participated, with 2862 vaccinated and 333 unvaccinated. We found that 95% of the unvaccinated were seropositive, with much lower titers than the vaccinated. Among the vaccinated, we found that Soberana recipients mounted the highest anti-spike response (mean ...
Tópico(s): Vaccine Coverage and Hesitancy
2024 - Multidisciplinary Digital Publishing Institute | Vaccines
María Eugenia-Toledo-Romaní, Mayra García Carmenate, Leslyhana Verdecia-Sánchez, Suzel Pérez-Rodríguez, Meiby Rodríguez-González, Carmen Valenzuela‐Silva, Beatriz Paredes-Moreno, Belinda Sánchez-Ramírez, Raúl González-Mugica, Tays Hernández-García, Ivette Orosa-Vázquez, Marianniz Díaz-Hernández, María Teresa Pérez-Guevara, Juliet Enríquez-Puertas, Enrique Noa-Romero, Ariel Palenzuela-Díaz, Gerardo Baró-Román, Ivis Mendoza-Hernández, Yaima Muñoz, Yanet Gómez-Maceo, Bertha Leysi Santos Vega, Sonsire Fernández-Castillo, Yanet Climent-Ruíz, Laura Rodríguez-Noda, Darielys Santana-Mederos, Yanelda García-Vega, Guang Wu-Chen, Delaram Doroud, Alireza Biglari, Tammy Boggiano-Ayo, Yury Valdés-Balbín, Daniel G. Rivera, Dagmar García-Rivera, Vicente Vérez-Bencomo, SOBERANA Research Group,
Background: SOBERANA 02 have been evaluated in phase I and IIa studies comparing homologous vs. heterologous schedule (this one, including ... report results of immunogenicity, safety and reactogenicity of SOBERANA 02 in a two-dose or three-dose heterologous ... SARS-CoV-2 RBD conjugated to tetanus toxoid (SOBERANA 02) and a third dose of dimeric RBD (SOBERANA ... apart; two production batches of active ingredient of SOBERANA 02 were evaluated. Primary outcome was the percentage of ... the most frequent AE. Conclusions: Two doses of SOBERANA 02 were safe and immunogenic in adults. The heterologous ...
Tópico(s): COVID-19 Clinical Research Studies
2022 - RELX Group (Netherlands) | SSRN Electronic Journal
Dagmar García-Rivera, Rinaldo Puga-Gómez, Sonsire Fernández-Castillo, Beatriz Paredes-Moreno, Yariset Ricardo-Delgado, Meiby Rodríguez-González, Carmen Valenzuela Silva, Rocmira Pérez-Nicado, Laura Rodríguez-Noda, Darielys Santana-Mederos, Yanet Climent-Ruíz, Enrique Noa-Romero, Otto Cruz-Sui, Belinda Sánchez-Ramírez, Tays Hernández-García, Ariel Palenzuela-Díaz, Marisel Martínez-Pérez, Arilia García-López, Yury Valdés-Balbín, Vicente Vérez-Bencomo,
Tópico(s): Heparin-Induced Thrombocytopenia and Thrombosis
2024 - Elsevier BV | Vaccine X
Tania L. Aguilar, Conner Gorry,
... fi rst COVID-19 candidates, SOBERANA 01 and SOBERANA 02.
Tópico(s): Public Health and Environmental Issues
2021 - | MEDICC Review
Tópico(s): Pneumonia and Respiratory Infections
2021 - Editorial Ciencias Médicas | Revista cubana de farmacia
Tammy Boggiano-Ayo, Julio Palacios-Oliva, Sumlai Lozada-Chang, Ernesto Relova-Hernández, Jose Alberto Gómez-Pérez, Gonzalo Oliva, Lourdes Hernández, Alexi Bueno-Soler, Daidee Montes de, Osvaldo Alves Mora, Roberto Machado-Santisteban, Dayana Pérez‐Martínez, Beatriz Pérez-Massón, Yanelys Cabrera Infante, Lisandra Calzadilla, Yaima Ramirez, Judey Aymed‐García, Ingrid Ruiz-Ramirez, Yamile Romero, Tania Gómez, Luis Ariel Espinosa, Luis Javier González, Annia Cabrales, Osmany Guirola, Kathya Rashida de la Luz, Franciscary Pi-Estopiñán, Belinda Sánchez-Ramírez, Dagmar García-Rivera, Yuri Valdés-Balbín, Gertrudis Rojas, Kalet Leon-Monzon, Eduardo Ojito-Magaz, Eugenio Hardy,
... vaccine formats, including SOBERANA 01 and the licensed SOBERANA 02, and SOBERANA Plus. Our approach involves expressing RBD (319-541)- ...
Tópico(s): Virus-based gene therapy research
2023 - Frontiers Media | Frontiers in Bioengineering and Biotechnology
... but no more effective and safe than Abdala, Soberana 02 and Corbevax. In addition, the institutional constraints of ...
Tópico(s): Biomedical Ethics and Regulation
2024 - Palgrave Macmillan | BioSocieties
... country to give emergency authorisation to Cuba’s Soberana 02 vaccine, Iran looks set to begin rolling it ...
Tópico(s): Healthcare Systems and Reforms
2021 - Emerald Publishing Limited | Emerald expert briefings
Xiaodi Wu, Ke Xu, Ping Zhan, Hongbing Liu, Fang Zhang, Yong Song, Tangfeng Lv,
... index (SUCRA value: 0.13), followed by BBV152, Soberana, Gam-COVID-Vac, and ZF2001. There were no significant differences among the various types of vaccines regarding the efficacy in preventing symptomatic SARS-CoV-2 infection, although there was a trend toward higher efficacy of the mRNA vaccines (SUCRA value: 0.09). BNT162b2 showed the highest efficacy (SUCRA value: 0.02) among the individual vaccines, followed by mRNA-1273, ...
Tópico(s): Vaccine Coverage and Hesitancy
2024 - BioMed Central | BMC Infectious Diseases
Jourdy Victoria James Heredia,
Portugal, Irlanda, Grecia y Espana, nombrados por sus iniciales los PIGS de la zona euro, desde el 2010 hasta la actualidad han reflejado desequilibrios fiscales considerables y niveles de endeudamiento que se han hecho inmanejables. A la vez que padecen profundas crisis en sus sistemas bancarios, pobres tasas de crecimiento economico y altos niveles de de desempleo. Ante esta situacion la investigacion analiza las diferentes politicas economicas (monetaria, fiscal), asi como el tipo de cambio en ...
Tópico(s): Global Financial Crisis and Policies
2014 - Servicios Academicos Intercontinentales | Contribuciones a la Economía
Enrique S López Loyo, Marino González, José Esparza,
... Cuban vaccine candidates (30 000 doses each of Soberana-2 and Abdala, which are undergoing clinical trials ...
Tópico(s): Global Public Health Policies and Epidemiology
2021 - Elsevier BV | The Lancet
... s external debt. La crisis de la deuda soberana suele considerarse como una de las principales causas ... un análisis riguroso que aclare si la deuda soberana de cada país está justificada. Este artículo muestra ... países importadores netos se encuentran con una deuda soberana debido al doble coste de las importaciones globales ...
Tópico(s): Global Financial Crisis and Policies
2017 - Elsevier BV | Cuadernos de Economía
Reseña de Munguía, Yadira (ed.), Enigmas ofrecidos a la soberana asamblea de la Casa del Placer de Sor Juana Inés de la Cruz , edición crítica, estudio y notas de Yadira Munguía, Pamplona, EUNSA, 2019, 299 pp. ISBN: 978-84-313-3368-3
Tópico(s): Historical Studies in Latin America
2019 - Instituto de Estudios Auriseculares (IDEA) | Hipogrifo Revista de literatura y cultural del Siglo de Oro
Tras la muerte de Isabel la Católica, se convierte en reina titular de Castilla su hija Juana. La enfermedad de la nueva soberana provoca que su padre, el rey Fernando, y su marido, Felipe el Hermoso, se enfrenten por el gobierno del reino. El humanista italiano Pedro Mártir de Anglería, testigo de estos acontecimientos, narra detalladamente en su epistolario el avance del conflicto entre los dos monarcas, retrata a los protagonistas y ofrece sus opiniones sobre esta crisis política en la que se ...
Tópico(s): Medieval and Early Modern Iberia
2022 - Instituto de Estudios Auriseculares (IDEA) | Hipogrifo Revista de literatura y cultural del Siglo de Oro
O direito administrativo, quando “importado” para o Brasil, passou por uma releitura no período Imperial sendo reformulado enquanto instrumento legitimador da posição política do monarca como fonte e fundamento do poder político nacional – uma função constitucional soberana ao invés de uma função tipicamente administrativa como em sua origem européia (Guandalini). Partindo dessa perspectiva é relevante estudar quais mutações o direito administrativo atravessou em outras etapas da história nacional, ...
Tópico(s): Public Health in Brazil
2023 - | Revista da AGU
... de la lucha por la independencia y la soberanAa. Defender la ConstituciA³n es, ahora, defender el ...
Tópico(s): Criminal Justice and Penology
2015 - Servicios Academicos Intercontinentales | Revista Caribeña de Ciencias Sociales
... entre líderes y Demo que enfatiza la autoridad soberana de éste, quien en definitiva los sometía a ...
Tópico(s): Historical and Literary Analyses
2019 - Spanish National Research Council | Emerita